SCHEMBL7160214

SCHEMBL7160214

O=C(Nc1ccc(NC(=S)Nc2ccncc2)cc1)c1ccco1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 8/20 0.71
NPC1 O15118 5/20 0.71
LMNA P02545 4/20 0.71
TP53 P04637 4/20 0.71
ALDH1A1 P00352 6/20 0.64
KDM4E B2RXH2 1/20 0.64
PTPN2 P17706 1/20 0.63
PTPN1 P18031 1/20 0.63
PTPN6 P29350 1/20 0.63
PTPN11 Q06124 1/20 0.63
MAPT P10636 5/20 0.62
POLB P06746 3/20 0.62
PKM P14618 1/20 0.62
BLM P54132 1/20 0.62
SMN1; SMN2 Q16637 5/20 0.60
MEN1 O00255 4/20 0.60
KMT2A Q03164 4/20 0.60
TSHR P16473 2/20 0.60
GAA P10253 2/20 0.60
HPGD P15428 3/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3975040 0.91 RAB9A (0.78) RAB9ANPC1LMNATP53ALDH1A1
SCHEMBL7164302 0.87 RAB9A (0.69) RAB9ANPC1LMNATP53ALDH1A1
SCHEMBL7662848 0.87 RAB9A (0.81) RAB9ANPC1LMNATP53ALDH1A1
SCHEMBL7159222 0.87 LMNA (0.82) RAB9ANPC1LMNATP53ALDH1A1
SCHEMBL7166487 0.86 RAB9A (0.57) RAB9ANPC1LMNATP53ALDH1A1
SCHEMBL7163812 0.83 SMN1; SMN2 (0.76) RAB9ANPC1LMNATP53ALDH1A1
SCHEMBL7848327 0.81 RAB9A (0.69) RAB9ANPC1LMNATP53ALDH1A1
SCHEMBL7743467 0.80 RAB9A (0.75) RAB9ANPC1LMNATP53ALDH1A1
SCHEMBL7161373 0.80 ALDH1A1 (0.66) LMNAALDH1A1KDM4EMAPTPOLB
SCHEMBL23412416 0.80 MAPK1 (0.72) RAB9ANPC1LMNATP53ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6555561-B2 N-(5-((((5-Chloro-2,4-dimethoxyphenyl)amino)thioxomethyl)-amino)-2 -pyridinyl)-2-methylbenzamide, for example; inhibiting replication of a herpes virus WYETH 2003-04-29 US disclosed